Core Scientific, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | -68.3% | -34.1% | +548.7% | |
| – | +53.7% | +254.8% | +577.7% | -57.3% | +24.5% | -42.6% | |
| – | +5.5% | +1,182.1% | +369.7% | -67.8% | -11.8% | +89.2% | |
| – | -471.6% | – | – | +601.0% | -105.0% | – | |
| – | -95.8% | +3,680.3% | +915.0% | -97.3% | +487.6% | +667.7% | |
| – | -59.5% | +2,698.7% | – | – | +3,077.3% | +678.2% | |
| – | – | – | – | +0.0% | -100.0% | – | |
| – | – | – | -80.8% | -137.9% | – | -101.3% | |
| – | +41.9% | +1,382.0% | -49.3% | -114.6% | – | -107.7% | |
| – | – | +6,678.2% | -164.6% | – | +4,292.2% | -168.5% | |
| – | – | – | – | – | -206.4% | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.